Table 4.
AP effects on degree of dysplasia and intestinal epithelial subtype in patients with IPMN
| Outcomes | IPMN | P-value | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|---|---|
| AP (n = 11) | Non-AP (n = 36) | OR | 95% CI | aOR | 95% CI | |||
| HGD | 4 (36.4) | 3 (8.3) | 0.042 | 6.29 | 1.14–34.57 | 3.92 | 0.62–24.85 | |
| IC | 2 (18.2) | 8 (22.2) | 1.000 | 0.78 | 0.14–4.35 | 0.69 | 0.11–4.44 | |
| Malignant (HGD + IC) | 6 (54.6) | 11 (30.6) | 0.171 | 2.73 | 0.68–10.87 | 2.00 | 0.44–9.07 | |
| Intestinal epithelial subtype | 3 (27.3) | 6 (16.7) | 0.419 | 1.88 | 0.38–9.20 | 1.92 | 0.31–11.83 | |
AP: acute pancreatitis; CI: confidence interval; HGD: high grade dysplasia; IC: invasive cancer; IPMN: intraductal papillary mucinous neoplasm; aOR: adjusted odds ratio
Adjusted for smoking and hypertension
Significant values are shown in bold